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There are approximately one billion people with disabilities globally. Despite thefact that disability affects roughly 15% of the global population, it is often
overlooked both in health policy and in research on health access.1 Therefore, not
only do people with disabilities experience disparities in health access and out-
comes, but their needs and experiences also remain invisible.2 In this issue of
JNCCN, Iezzoni et al3 draw attention to this population, exploring the association
between disability and cancer in the United States. This is one of the few studies that
focus specifically on examining incidence of cancer among people with disabilities, a
particularly important yet underexplored issue. Although there is a growing body of
evidence on disparities in cancer service utilization for people with disabilities,
predominantly screening and diagnostic services, limited information is available on
cancer incidence.
People with disabilities are among the most disadvantaged population groups;
they often experience structural disadvantage in the form of increased poverty levels,
lower literacy levels, and higher rates of unemployment or informal employment
compared with the general population.4 Such structural disadvantage intersects with
“ableism,” which is discrimination against people with disabilities and the expectation
that all bodies can or ought to conform to an idealised nondisabled norm. This
intersection leads to compromised access to healthcare services and to living
conditions linked to poorer health. Direct and indirect discrimination against people with
disabilities can lead to increased barriers to accessing healthcare and reduced use of
cancer services.
An increasing body of evidence indicates lower participation in cancer screening
for people with disabilities, due to a number of physical, institutional, financial, and
attitudinal barriers. Such barriers include inaccessible healthcare facilities and/or
equipment, lack of social support, financial constraints, past negative experiences
with healthcare professionals, discomfort, inadequate information, lack of or in-
appropriate transport, and inadequate training of healthcare professionals, among
other factors.5,6 Similar sets of barriers and patterns of disparities are observed
globally across different healthcare systems; evidence suggests that people with
disabilities experience worse access to cancer screening not only in the United States7
but also across the world, including even in countries with universal health coverage
and public healthcare that is free at the point of delivery, such as the United Kingdom.8
Various studies also underline the existence of disparities in cancer treatment
and substandard experiences of service provision.9,10 Behind the statistics of cancer
screening underuse are human stories: men and women with disabilities
who—worried about new, unfamiliar symptoms—try to get screened but whom
doctors are reluctant to refer, possibly due to diagnostic overshadowing; wheelchair
users being asked to stand up; and healthcare professionals not exploring ways to
adapt processes to make them disability-inclusive, exemplifying a general lack of
disability inclusiveness in the provision of healthcare services.10,11
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The study by Iezzoni et al3 provides novel insights and much-needed
knowledge about the associations between disability and cancer incidence in
the United States. The researchers used a nationally representative survey—the
2010–2017 National Health Interview Surveys—to investigate the relationship
between disability and four common types of cancer: colorectal, prostate,
ovarian, and non-Hodgkin’s lymphoma. The study included people who had
movement difficulties or complex activity limitations that predated the cancer
diagnosis. In line with existing evidence, Iezzoni et al3 found that people with
disabilities were older, had lower education levels, were generally poorer, had a
higher body mass index, and were more likely to have a smoking history. Im-
portantly, study findings showed that people with preexisting disabilities had
significantly higher rates of cancer and that they were older when initially di-
agnosed compared with people without disability. Multivariable regressions,
accounting for sociodemographic and risk factor characteristics, showed that
preexisting disability—disability that predated the cancer diagnosis and was not
a result of cancer—was strongly associated with colorectal and prostate cancers,
and non-Hodgkin’s lymphoma.
The study findings may be alarming, but they are also unsurprising considering
the barriers that people with disabilities experience when seeking screening services.
The study should serve as a call to action for policymakers, healthcare managers, and
clinicians. Even when people with disabilities do access these services, diagnostic
overshadowing, which is the erroneous attribution of new symptoms to a patient’s
preexisting disability, may delay cancer diagnosis. The study underlines the need to
ensure the provision of appropriate screening and comprehensive exploration of all
new signs and symptoms for people with disabilities, in order to ensure timely
diagnosis.
The evidence provided by Iezzoni et al3 adds real urgency to the need to work
toward reducing cancer disparities for people with disabilities, through taking a twin-
forked approach, focusing both on the provision of disability-inclusive healthcare,
including cancer services, and on the exploration and reduction of increased cancer
incidence. It is important to disaggregate existing cancer data by disability in order to
understand the mechanisms associated with cancer disparities for people with
disabilities. Although a wealth of cancer-related evidence is available, databases
often do not include information on disability, making it very difficult to measure
disability-based disparities. The invisibility of this population in cancer statistics might
contribute to their needs being overlooked. Ensuring that all cancer data include the
WashingtonGroupquestions,12 which aim to identify peoplewith disabilities in datasets,
can provide visibility for this population in cancer statistics. This would allow an in-depth
exploration of the interactions between factors such as age, sex, disability, and illness
and environmental influences, including geographic location, government policies, and
the natural and built environment, in order to better understand disparities in cancer
screening, incidence, stage at diagnosis, treatment, and outcomes for people with
disabilities.
Making disability-disaggregated data available is one step toward bridging
cancer disparities for people with disabilities. This needs to be coupled with an effort
to make all health services disability-inclusive, because the mere existence of ser-
vices does not guarantee accessibility and usability. To ensure that cancer services
are disability-inclusive and ultimately accessible, they must be available, affordable,
relevant, appropriate, and acceptable to service users with disabilities. All of these
dimensions of accessibility are equally important, and they interact with each other to
facilitate or inhibit access to services. Although the Americans with Disabilities Act
in the United States and similar pieces of legislation across the world, including the
United Nations Convention on the Rights of Persons with Disabilities, explicitly
prohibit disability-based discrimination in healthcare, people with disabilities face
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several barriers when they seek to access services. These
barriers must be identified and addressed.
It is important that policymakers work toward inclusive
cancer care provision through the introduction of public
health campaigns that promote inclusive preventive services.
Health professionals need to receive appropriate education
and training regarding disability in order to dispel assump-
tions and negative attitudes.13 Listening to people with dis-
abilities who have cancer is one of the most effective ways to
change practice and create inclusive cancer services. Fur-
thermore, better communication among various professionals
and across different teams involved in a patient’s care is
paramount and can help raise awareness of how disability
can interact with cancer-related care. At the same time, the
creation of more accessible environments is crucial, in-
cluding screening equipment such as that used for mam-
mograms, and treatment processes such as radiotherapy.
As the population ages and an increasing number of
people live with cancer and disability, ensuring that cancer
services are disability-inclusive is more imperative than ever.
Early and fast diagnosis, equity of access to treatment and
care, and inclusive health promotion campaigns are key for
the development of healthcare services that better respond
to the needs of people with disabilities. Improving cancer out-
comes is a complex endeavour that cannot be realized
without the explicit consideration of people with disabilities
and their participation in the decision-making processes.
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